Adynxx Inc.
NASDAQ:ADYX (6/12/2019, 7:08:49 PM)
After market: 3.65 +0.04 (+1.11%)3.61
-2.33 (-39.23%)
Adynxx Inc. is a clinical-stage biopharmaceutical company. It is focused on therapeutics for the treatment of pain and inflammatory diseases. Adynxx Inc., formerly known as Alliqua BioMedical Inc., is based in San Francisco, United States.
Adynxx Inc.
2150 CABOT BLVD WEST SUITE B
LANGHORNE PA 19047
P: 215-702-8550
CEO: David Johnson
Award of More than $600K Will Support Advancement of AYX2 for Chronic Pain to IND-Enabling Studies
Adynxx (OTC:ADYX) has filed a preliminary prospectus for a $15M public offering of common stock or pre-funded warrants. Price, volume and terms have yet to be announced.
COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.
Here you can normally see the latest stock twits on ADYX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: